Trial ID or NCT#

NCT01132495

Status

NOT RECRUITING

Purpose

The overall purpose of the FAME II trial is to compare the clinical outcomes, safety and cost-effectiveness of FFR-guided PCI plus optimal medical treatment (OMT) versus OMT alone in patients with stable coronary artery disease.

Official Title

Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease

Eligibility Criteria

Ages Eligible for Study: Older than 21 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

William Fearon, MD
Interventional cardiologist, Cardiologist
Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Todd Brinton
Interventional cardiologist, Cardiologist
Clinical Professor, Medicine - Cardiovascular Medicine
Alan Yeung, MD
Interventional cardiologist, Cardiologist
The Li Ka Shing Professor in Cardiology
David Lee, MD
Interventional cardiologist, Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Jennifer Tremmel
Interventional cardiologist, Cardiologist
Assistant Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Maria Perlas
(650) 723-2094